DDrare: Database of Drug Development for Rare Diseases

Allogeneic stem cell transplant (DrugBank: -)

2 diseases

ID	Disease name (Link within this page)	Number of trials
53	Sjogren syndrome	1
56	Behcet disease	1

53. Sjogren syndrome [ 234 clinical trials, 270 drugs, (DrugBank: 85 drugs), 49 drug target genes, 174 drug target pathways]

Searched query = "Sjogren syndrome", "Sjögren syndrome"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

1 / 234 trial found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00278512 (ClinicalTrials.gov)	August 2003	15/1/2006	Hematopoietic Stem Cell Support in Vasculitis	High Dose Immune Suppression With Hematopoietic Stem Cell Support in Refractory Vasculitis, Necrotizing Vasculitis, Neurovascular Behcet's Disease, and Sjogren's Syndrome	Vasculitis	Biological: Autologous Stem Cell Transplant;Biological: Allogeneic Stem Cell Transplant	Northwestern University	NULL	Terminated	16 Years	60 Years	Both	7	Phase 1	United States

56. Behcet disease [ 68 clinical trials, 87 drugs, (DrugBank: 31 drugs), 36 drug target genes, 113 drug target pathways]

Searched query = "Behcet disease", "Behçet disease"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

1 / 68 trial found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00278512 (ClinicalTrials.gov)	August 2003	15/1/2006	Hematopoietic Stem Cell Support in Vasculitis	High Dose Immune Suppression With Hematopoietic Stem Cell Support in Refractory Vasculitis, Necrotizing Vasculitis, Neurovascular Behcet's Disease, and Sjogren's Syndrome	Vasculitis	Biological: Autologous Stem Cell Transplant;Biological: Allogeneic Stem Cell Transplant	Northwestern University	NULL	Terminated	16 Years	60 Years	Both	7	Phase 1	United States